Monthly Roundup -- February 2015
Here is our look-back at the key whistleblower and fraud developments we have written about over the past month:
FEATURED POSTS AND COMMENTARY
This month’s featured posts and commentary included: DOJ Gets Failing Marks For Treatment Of FBI Whistleblowers (here); New York AG Proposes Financial Frauds Whistleblower Act (here); Seventh Circuit Gives Broad Read To What Constitutes A “Referral” Under Anti-Kickback Statute (here); War On Whistleblowers Continues To Sink United States World Press Freedom Ranking (here); Does the FDA Hide Evidence of Clinical Fraud? (here); Department of Defense Moves To Bar Anti-Whistleblower Confidentiality Provisions (here); Fourth Circuit Joins Other Circuits In Narrow Read of Public Disclosure Bar (here).
DOJ CATCH OF THE WEEK
WHISTLEBLOWER NEWS FROM THE INSIDE
DOJ Fraud Settlements
The DOJ settled False Claims Act and other fraud allegations with MetLife Home Loans, Santander, AstraZeneca, Good Shepherd Hospice, ResCare, Medtronic, Standard & Poor’s, Minebea, Community Health Systems, among others, for a total recovery of more than $1.5 billion. Many of these matters were initiated by whistleblowers under the qui tam provisions of the False Claims Act. Click here.